Cutler Group LP Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$171.37 - $283.23 $3.31 Million - $5.47 Million	-19,300 Reduced 34.34%	36,900 $1.09 Million
Q4 2023 Jan 18, 2024	SELL	$120.4 - $237.13 $3.29 Million - $6.47 Million	-27,300 Reduced 32.69%	56,200 $746,000
Q3 2023 Nov 07, 2023	BUY	$146.04 - $225.78 $5.65 Million - $8.74 Million	38,700 Added 86.38%	83,500 $248,000
Q2 2023 Jul 18, 2023	SELL	$203.88 - $312.0 $2.73 Million - $4.18 Million	-13,400 Reduced 23.02%	44,800 $511,000
Q1 2023 May 01, 2023	BUY	$231.06 - $307.08 $300,378 - $399,204	1,300 Added 2.28%	58,200 $4.16 Million

Q4 2022 Feb 07, 2023	BUY	$58.39 - $296.54 $3.32 Million - $16.9 Million	56,900 New	56,900 $7.17 Million
Q2 2022 Aug 04, 2022	BUY	$58.04 - $100.2 $232,160 - $400,800	4,000 Added 800.0%	4,500 $4,000
Q1 2022 Apr 14, 2022	SELL	$55.89 - $101.89 $5,589 - $10,189	-100 Reduced 16.67%	500 $3,000
Q4 2021 Jan 18, 2022	SELL	$72.34 - $95.09 $36,170 - $47,545	-500 Reduced 45.45%	600 $5,000
Q3 2021 Oct 26, 2021	BUY	$78.35 - $105.02 $70,515 - $94,518	900 Added 450.0%	1,100 $7,000
Q2 2021 Jul 19, 2021	SELL	$97.2 - $137.59 $87,480 - $123,831	-900 Reduced 81.82%	200 $1,000
Q1 2021 Apr 26, 2021	SELL	$108.54 - $125.2 $54,270 - $62,600	-500 Reduced 31.25%	1,100 $9,000
Q4 2020 Jan 21, 2021	BUY	$110.06 - $133.7 $66,036 - $80,220	600 Added 60.0%	1,600 $11,000
Q3 2020 Oct 27, 2020	SELL	$99.78 - $124.21 $179,604 - $223,578	-1,800 Reduced 64.29%	1,000 $1,000
Q2 2020 Jul 22, 2020	SELL	$60.13 - $125.71 $258,559 - $540,553	-4,300 Reduced 60.56%	2,800 $42,000
Q2 2019 Aug 09, 2019	SELL	$91.13 - $142.5 $628,797 - $983,250	-6,900 Reduced 49.29%	7,100 $31,000
Q1 2019 May 10, 2019	SELL	$103.48 - $143.84 $476,008 - $661,664	-4,600 Reduced 24.73%	14,000 $21,000
Q4 2018 Feb 05, 2019	BUY	$94.77 - $215.54 $416,988 - $948,376	4,400 Added 30.99%	18,600 $45,000
Q3 2018 Nov 07, 2018	BUY	$207.3 - $300.31 $1.84 Million - $2.67 Million	8,900 Added 167.92%	14,200 $31,000
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $538,215 - $1.66 Million	5,300 New	5,300 $45,000

Others Institutions Holding MDGL

# of Institutions

313

Shares Held

20M

Call Options Held

824K

Put Options Held

1.04M

Janus Henderson Group PLC London, X0

2.6M
Shares

$614 Million
0.39% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$465 Million
6.66% of portfolio
Avoro Capital Advisors LLC New York, NY

1.94M
Shares

$459 Million
6.26% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

1.78M
Shares

$419 Million
34.28% of portfolio
Vanguard Group Inc Valley Forge, PA

1.67M
Shares

$394 Million
0.01% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $4.04B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account